نتایج جستجو برای: ssri

تعداد نتایج: 1849  

Journal: :فصلنامه علمی پژوهشی گیاهان دارویی 0
p mansoori school of pharmacy, tehran university of medical sciences s akhondzadeh school of pharmacy, tehran university of medical sciences f raisi school of pharmacy, tehran university of medical sciences p ghaeli psychiatric research centre, roozbeh hospital, tehran university of medical sciences, soutk kargar street, tehran 13337, iran tel: +98-21-55412222, fax: +98-21- 5541-9113 ah jamshidi department of pharmacognosy and pharmaceutics, institute of medicinal plants, acecr aa nasehi school of pharmacy, tehran university of medical sciences

background: recent studies have indicated potential of saffron for applying in a wide variety of diseases such as psychiatric and neurologic disorders. the concurrent use of saffron with ssris can lead to reducing the dose of ssris. saffron at a dose of 200 mg may change some hematological and biochemical parameters. objective: the goal of this trial was to assess the safety of concomitant admi...

ژورنال: :annals of military and health science research 0
حمزه شاه علی h shahali (*corresponding author) medical researcher, army university of medical sciences, tehran, iran محمد حسین شاه علی mh shahali medical researcher, tehran university of medical sciences, tehran, iran tel: 09123402801

سابقه وهدف: دیابت یکی از معضلات پزشکی عصر ما بوده و کنترل مناسب قند خون مهمترین هدف درمان بیماران مبتلا به دیابت است تا بتوان در حد امکان از میزان عوارض بلند مدت هیپرگلایسمی کاسته شود. لیکن پلان نیز به عنوان یک بیماری پوستی مزمن به دلیل درمان های بلند مدت و صرفاً علامتی باعث ایجاد مشکلات عدید های مانند مشکلات زیبایی شده و میزان پذیرش درمان در بیماران پایین است. لذا تحقیق و پژوهش در زمینه کنترل د...

2007
Laura Baldassari Jennifer Wilcox Thomas Mc Laughlin

Depression is a serious illness that affects 20.9 million Americans a year. The most common method of treatment is selective serotonin reuptake inhibitors (SSRIs). Previous studies have shown that SSRI efficacy is limited. This review of current clinical data combined with statistical analyses has shown that the efficacy of SSRI treatment in adolescents is even more limited. It also has shown t...

Journal: :Down's syndrome, research and practice : the journal of the Sarah Duffen Centre 2006
Bruce Sutor Mark R Hansen John L Black

In this case series we report four cases of patients with Down syndrome with symptoms consistent with obsessive compulsive disorder. Each patient experienced substantial reduction in compulsive behaviors with pharmacotherapy of an SSRI alone or with the addition of risperidone to SSRI therapy. None of the patients experienced significant side effects. This small case series supports the use of ...

2013
Pierre-Eric Lutz

Lutz P.-E. Multiple serotonergic paths to antidepressant efficacy. J Neurophysiol 109: 2245–2249, 2013. First published January 23, 2013; doi:10.1152/jn.01093.2012.—Depression is a leading cause of disability worldwide. Brain mechanisms underlying the clinical antidepressant efficacy of selective serotonin reuptake inhibitors (SSRI), currently the first-line treatment, remain poorly understood....

Journal: :The Journal of clinical psychiatry 2011
Mario F Mendez

To the Editor: Pathological stealing is kleptomanic behavior due to brain disease. As with kleptomania, there is an inability to resist stealing unneeded objects of insignificant value.1 Kleptomania may be related to obsessive-compulsive disorder (OCD) and could respond to selective serotonin reuptake inhibitor (SSRI) medications, the treatment of choice for OCD.2,3 Herein, we report 4 frontote...

Journal: :British Journal of Psychiatry Open 2023

Aims Serotonin in platelets has a major role promoting vasoconstriction and platelet aggregation. Selective serotonin reuptake inhibitors (SSRIs), which are widely used clinically, inhibit the transporter responsible for uptake into platelets. This depletion reduces clot formation, thus increasing bleeding risk. risk is particularly elevated older adults who also more likely to have co-morbid p...

2005
Kristin Zerumsky

Patients are often required to “cross over” between selective serotonin reuptake inhibitors (SSRIs) because of cost savings or a lack of the agent’s effectiveness. Pharmacokinetics, serotonin syndrome, and withdrawal symptoms must be considered when therapy is changed. This review analyzes the data available regarding changing from one SSRI to another; however, the findings are inconclusive in ...

2011
Murad Atmaca Sevda Korkmaz Mehtap Topuz Osman Mermi

The aim of the present study was to retrospectively identify sexual dysfunction changes in the patients under mirtazapine-augmented serotonin reuptake inhibito (SSRI) treatment. The study comprised medical records of 20 outpatients, under mirtazapine-augmented SSRI treatment for their major depressive disorder, who had been selected among the patients that had developed sexual dysfunction to pr...

Journal: :The international journal of neuropsychopharmacology 2002
Adam Opbroek Pedro L Delgado Cindi Laukes Cindy McGahuey Joanna Katsanis Francisco A Moreno Rachel Manber

Anecdotal and published case reports suggest that some patients taking selective serotonin reuptake inhibitors (SSRI) experience diminution in emotional responsiveness. This study aims to define the individual components of emotion disturbed in these patients. Fifteen patients reporting SSRI-induced sexual dysfunction completed the Laukes Emotional Intensity Scale (LEIS), a questionnaire about ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید